(Q43479669)

23 November 2017

Efficacy and safety of moricizine in patients with congestive heart failure: A summary of the experience in the United States (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80073-0

Cardiology and cardiovascular medicine

29 October 2022

main subject

congestive heart failure

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80073-0

29 October 2022

author name string

C. M. Pratt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688682

29 October 2022

P. Podrid

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688682

29 October 2022

B. Greatrix

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688682

29 October 2022

R. M. Borland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688682

29 October 2022

S. Mahler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688682

29 October 2022

language of work or name

English

0 references

publication date

1 January 1990

1 reference

full work available at URL

23 November 2017

https://api.elsevier.com/content/article/PII:S0002870305800730?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80073-0

https://api.elsevier.com/content/article/PII:S0002870305800730?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(05)80073-0

29 October 2022

published in

American Heart Journal

1 reference

23 November 2017

119

1 reference

23 November 2017

1

1 reference

23 November 2017

1-7

1 reference

Determinants of survival in patients with ventricular tachyarrhythmias

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Clinical predictors of arrhythmia worsening by antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Ventricular Premature Beats and Mortality after Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Effects of flecainide on ventricular function: clinical and experimental correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Safety and efficacy of encainide for malignant ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Congestive heart failure caused by oral disopyramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980073-0

7 January 2021

Identifiers

1 reference

23 November 2017

1 reference